Area of research
Rheumatology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Systemic Lupus Erythematosus Research, Monoclonal and Polyclonal Antibodies Research, T-cell and B-cell Immunology, and Rheumatoid Arthritis Research and Therapies.
ERN ReCONNET–SLICC–SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations
MACHINE LEARNING CAN IDENTIFY AN ANTINUCLEAR ANTIBODY PATTERN THAT MAY RULE OUT SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES
Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step Toward Precision Drug Monitoring
An update on autoantibodies in the idiopathic inflammatory myopathies
Platelets and Thrombotic Antiphospholipid Syndrome
Can complement activation be the missing link in antiphospholipid syndrome?
The impact of antiphospholipid antibodies/antiphospholipid syndrome on systemic lupus erythematosus
Where are we now in biologic drugs for myositis?
ACK1 and BRK non-receptor tyrosine kinase deficiencies are associated with familial systemic lupus and involved in efferocytosis
Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus
Defining an Ageing-Related Pathology, Disease or Syndrome: International Consensus Statement
ACK1 and BRK non-receptor tyrosine kinase deficiencies are associated with familial systemic lupus and involved in efferocytosis
POS1247 CHARACTERIZATION OF 284 PATIENTS PRESENTING WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT AT DIAGNOSIS OF SJÖGREN DISEASE: RESULTS FROM THE SJÖGREN BIG DATA REGISTRY
International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative
Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes
Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the <scp>SLICC</scp> Inception Cohort
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases
Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registry
Targeted Therapy for SLE—What Works, What Doesn’t, What’s Next
Promising Experimental Treatments for Lupus Nephritis: Key Talking Points and Potential Opportunities
Complement Activation Is Increased in Antiphospholipid Syndrome-Related Ischemic Stroke with Higher Risk Features
British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy
Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort
Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies
Anti-rituximab antibodies demonstrate neutralizing capacity, associate with lower circulating drug levels and earlier relapse in lupus
Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine
2021 DORIS definition of remission in SLE: final recommendations from an international task force
Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohort
Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort